| Followers | 54 |
| Posts | 6684 |
| Boards Moderated | 0 |
| Alias Born | 01/11/2017 |
Monday, October 11, 2021 7:09:12 PM
This has always been Nader’s playbook! State inaccurate or misleading info on a call (“I sold shares to pay the Samsung bill and help the company”! Remember that doozy!)
Then he loads the message boards with these narratives that take on a life of their own, then BAM, the 8k comes out with the “REAL” info but it’s too late.
All this nonsense with 82% has already been factually DEBUNKED as data mined from a subset of a subset. Also, Nader chose the CRO and didn’t listen to the DSMC, which again was hired by Nader!!
That is why the FDA slapped him down and he had to admit it on a conference call and beg his mouthpieces to stop badgering government departments.
Rinse, wash, repeat! There’s no info from Brazil because he knows he’s being watched. If the preliminary data was even a little bit good, he’d be all over the air waves but he knows the FDA, DOJ and SEC are watching.
He’s a lying, narcissistic thief who will never stop stealing until they frog walk him out in an orange jumpsuit! That’s what’s next!
Bankruptcy imminent once they stopped paying their most vital partners, especially the CRO. Amarex will and has come out swinging but again, he set the narrative
Amarex bad
Cytodyn victim.
It’s over- just waiting for the final scene of this Netflix horror show of “Iranian Greed”
Then he loads the message boards with these narratives that take on a life of their own, then BAM, the 8k comes out with the “REAL” info but it’s too late.
All this nonsense with 82% has already been factually DEBUNKED as data mined from a subset of a subset. Also, Nader chose the CRO and didn’t listen to the DSMC, which again was hired by Nader!!
That is why the FDA slapped him down and he had to admit it on a conference call and beg his mouthpieces to stop badgering government departments.
Rinse, wash, repeat! There’s no info from Brazil because he knows he’s being watched. If the preliminary data was even a little bit good, he’d be all over the air waves but he knows the FDA, DOJ and SEC are watching.
He’s a lying, narcissistic thief who will never stop stealing until they frog walk him out in an orange jumpsuit! That’s what’s next!
Bankruptcy imminent once they stopped paying their most vital partners, especially the CRO. Amarex will and has come out swinging but again, he set the narrative
Amarex bad
Cytodyn victim.
It’s over- just waiting for the final scene of this Netflix horror show of “Iranian Greed”
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
